Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

February 22, 2016 Cover

Volume 94, Issue 8

At the JPMorgan Healthcare Conference in San Francisco, executives from Forge Therapeutics seek the backing they need to move forward

Full Article
Volume 94 | Issue 8

All Issues

  • Nanoparticle Synthesis Paper Retracted After 12 Years

    Science withdraws paper after NSF finds poor research practices and data misrepresentation

  • How Pharma Services Firms Are Meeting The Drug Industry’s Needs

    Suppliers amass custom chemicals assets and expertise to attract clients

  • U.S. Budget Request Increases Science Funding, But Largely Thanks To Accounting Trick

    Science research not likely to see the full 4% increase found in the White House’s proposed 2017 budget, and some agencies set to lose

ADVERTISEMENT
image name
Synthesis

Another Way To Functionalize Alkynes

Organic Synthesis: tert-Butyl nitrite offers a metal-free approach to alkyne bond breaking and aryl nitrile making

ADVERTISEMENT
ADVERTISEMENT